Advertisements

Heparin Sodium Injection

Quick links to important sections

Heparin Sodium Injection

Advertisements
Advertisements

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Heparin Sodium Injection

Property Description
Active ingredient Heparin sodium
Form Solution for Injection (Parenteral)
Pharmacological class Antithrombotic Agent
General purpose Rapid prevention of blood clotting
Origin Biological origin (typically porcine mucosa)

Heparin Sodium Injection: Definition and Pharmacological Class

Heparin Sodium Injection is a sterile, injectable pharmaceutical preparation classified as an Antithrombotic Agent used to prevent the formation of blood clots. The medication is an anticoagulant, often called a blood thinner, which functions to inhibit coagulation. This helps ensure that blood flow remains unobstructed, which is intended for patients requiring immediate, high-level anticoagulation. The active component, Heparin sodium, belongs to the specific pharmacological category of an Indirect Thrombin and Factor Xa Inhibitor. This product is known as Unfractionated Heparin (UFH), used in the healthcare setting for its capacity for rapid, titrated therapeutic effect.


Composition, Origin, and Pharmaceutical Form

The medicine is a parenteral preparation consisting of a clear, single-component solution for injection with the active substance dissolved in Water for Injection. The active ingredient is chemically a large, highly sulfated glycosaminoglycan (a type of polysaccharide), which is notable for its biological origin; the substance is generally derived and purified from porcine intestinal mucosa. It is typically available as a prescription-only medicine (Rx) and its high molecular weight provides it with a unique mechanism of action compared to newer synthetic agents.


The General Purpose of Unfractionated Heparin

Due to its complex structure, Heparin acts by binding to the natural anticoagulant protein Antithrombin. The fundamental purpose of Unfractionated Heparin is the rapid prevention of blood clotting and the extension of existing clots within the vascular system. It provides a means of maintaining optimal blood fluidity in high-risk scenarios, such as the acute management of a suspected deep vein thrombosis.

Regulatory References

  1. NIH/NLM Heparin Overview
  2. NIH Heparin Mechanism
Advertisements

What side effects are possible with Heparin Sodium Injection?

Possible Side Effects and Safety Information

The most common and clinically significant risk associated with Heparin Sodium Injection is hemorrhage (bleeding), which can be severe or fatal. The risk of bleeding may be higher in older patients, particularly women over 60 years of age, and in those with pre-existing conditions that increase the risk of hemorrhage.

Serious and Clinically Significant Adverse Reactions

  • Hemorrhage: Can occur at virtually any site in the body, including internal bleeding. Unexplained drops in blood pressure or hematocrit should prompt an evaluation for a hemorrhagic event.
  • Heparin-Induced Thrombocytopenia (HIT) and Thrombosis (HITT): This is a serious, immune-mediated condition characterized by a significant drop in platelet count (thrombocytopenia), which can lead to the formation of new, dangerous blood clots (thromboses) in both veins and arteries, potentially resulting in limb loss or death. HITT can occur up to several weeks after heparin discontinuation.
  • Hypersensitivity: Allergic reactions, including severe anaphylaxis, have been reported. Heparin is derived from porcine (pig) tissue and is contraindicated in patients with a history of hypersensitivity to heparin or pork products.
  • Other Adverse Effects: Other documented adverse reactions include skin necrosis, alopecia (hair loss), and elevation of serum aminotransferase levels (which may indicate liver effects).

Contraindications and Safety Monitoring

Heparin is contraindicated in patients with a history of HIT or HITT, in those with severe thrombocytopenia, or in the presence of an uncontrolled active bleeding state (except when related to disseminated intravascular coagulation).

Regular monitoring of platelet counts is essential to detect HIT. For patients receiving full-dose therapy, frequent blood coagulation tests (such as the aPTT) are used to help guide treatment and maintain a safe anticoagulant effect. Due to the potential for fatal errors, care must be taken to confirm the correct product strength prior to administration. Heparin formulations containing the preservative benzyl alcohol are not recommended for use in neonates and infants due to the risk of serious adverse effects.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The principal manifestation of overdose with Heparin Sodium Injection is hemorrhage (bleeding), which is the primary consequence of excessive anticoagulation documented in regulatory labeling. Officially documented clinical signs include easy bruising, epistaxis, hematuria, and melena, alongside the laboratory finding of an unduly prolonged activated partial thromboplastin time (aPTT).


Life-Threatening Risks

The most severe outcomes cited in official documents are fatal hemorrhage and major internal bleeding, such as intracranial or retroperitoneal hemorrhage, which can lead to hypotension and circulatory shock. Regulators note a higher incidence of bleeding in patients over 60 years of age and those with severe renal disease.


Required Emergency Actions

A suspected overdose requires immediate medical attention and treatment. For signs of severe complication, such as collapse, seizure, trouble breathing, or unresponsiveness, emergency services must be contacted immediately. Treatment involves promptly discontinuing the drug and administering the specific antidote, Protamine Sulfate, which is officially documented as a heparin antagonist. Supportive measures include necessary blood product replacement to manage acute blood loss.

Advertisements

Therapeutic Uses of Heparin Sodium Injection

What Heparin Sodium Injection Treats: Main Uses and Benefits

Heparin Sodium Injection is an anticoagulant used in situations involving certain distressing symptoms related to excessive blood clotting. Its main therapeutic domain is the prophylaxis and treatment of venous thromboembolism (VTE), which includes deep vein thrombosis and pulmonary embolism.

The injection is commonly used across conditions presenting with acute episodes to prevent clot formation and may assist with managing the progression of existing clots. This may assist with reducing symptoms that create noticeable physiological strain caused by blocked blood flow. The injection is considered relevant for easing the symptoms associated with: thromboembolic complications of atrial fibrillation, prophylaxis and treatment of peripheral arterial embolism, and acute and chronic consumptive coagulopathies.

The medication is commonly used in clinical settings for supporting functional stability during high-stress procedures. This supportive therapy assists with maintaining functional stability when treating patients with acute clot risk. In addition to therapeutic uses, it is applied as an anticoagulant to prevent clotting during procedures such as arterial and cardiac surgery, extracorporeal circulation (like dialysis), and blood transfusions. Overall, this supportive relief contributes to easing the overall symptom load and helps improve day-to-day comfort during symptomatic phases.


Quick Fact: Relief for Symptoms related to excessive blood clotting

Regulatory References

  1. NIH DailyMed Label
Advertisements

Eligibility and Restrictions for Use

The eligibility to use Heparin Sodium Injection is determined by strict rules in regulatory labeling, primarily due to the risk of hemorrhage and hypersensitivity.


Contraindicated Populations (Absolute Non-Eligibility)

Use is absolutely prohibited in patients with a known history of Heparin-Induced Thrombocytopenia (HIT), severe thrombocytopenia, or known hypersensitivity to heparin or pork products. It is also contraindicated in any patient experiencing an uncontrolled active bleeding state, with the exception of use for Disseminated Intravascular Coagulation (DIC).


Age-Related and Conditional Restrictions

Population Group Regulatory Status
Pediatric Patients Safety and effectiveness have not been established (preservative-free formulation is recommended for neonates and infants).
Older Adults (Aged 65+) Eligible, but have an increased risk of hemorrhage and require close monitoring.
Pregnancy/Lactation Acceptable for use as the large molecule does not cross the placenta or pass into breast milk in clinically significant amounts.

Use requires extreme caution in populations with conditions that increase bleeding risk, such as Subacute Bacterial Endocarditis (SBE), severe hepatic or renal impairment, or immediately following major surgery involving the brain, spinal cord, or eye.

Advertisements

What should I know about interactions with other medicines?

The interaction profile for Heparin Sodium Injection is defined primarily by additive effects with other agents that affect hemostasis, which may induce an increased risk of hemorrhage. Regulatory documents define these interactions and impose specific constraints.

Interacting Substance Category Interaction Outcome (Regulatory Statement) Interaction Type
Platelet Inhibitors (e.g., NSAIDs, Aspirin) May induce bleeding due to interference with platelet-aggregation reactions. Additive Hemostatic Risk
Oral Anticoagulants (e.g., Warfarin) Prolongs the prothrombin time; requires timing separation for valid laboratory tests. Pharmacodynamic
Potassium-Sparing Drugs Increases the risk of hyperkalemia due to suppression of adrenal aldosterone secretion. Electrolyte Alteration
Antagonistic Agents (e.g., Nicotine, Digitalis) May partially counteract the anticoagulant action of heparin. Effect Counteraction

Interaction-Related Restrictions

Intravenous Diclofenac is formally contraindicated for co-administration due to the heightened risk of hemorrhage. The medication is chemically incompatible with numerous substances (e.g., Alteplase) and must not be admixed in the same intravenous line.

Timing Constraint

When converting to an oral anticoagulant, a period of at least five hours (after an IV dose) or twenty-four hours (after a subcutaneous dose) must elapse before drawing blood for a valid Prothrombin Time (PT) test result.

Population-Specific Note

The anticoagulant effect is officially noted to be enhanced when co-administered with Antithrombin III (human) in patients with hereditary Antithrombin III deficiency.

Advertisements

Mechanism of Action

How Heparin Sodium Injection Works


The mechanism of action for Heparin Sodium (Unfractionated Heparin) is defined by its role as an allosteric modulator and catalytic template for the endogenous serine protease inhibitor, Antithrombin III (AT). Heparin binds to a specific pentasaccharide sequence on the AT molecule, inducing a rapid conformational change that accelerates AT's ability to neutralize activated coagulation factors by approximately 1,000-fold.

This molecular potentiation immediately targets two pivotal enzymes in the common coagulation pathway: Activated Factor X (Factor Xa) and Thrombin (Factor IIa). Inhibition of Factor Xa blocks the generation of Thrombin, while inhibition of Thrombin prevents the conversion of fibrinogen into Fibrin. The longer polymer chains of Heparin are required to simultaneously bridge AT and Thrombin, forming a ternary complex necessary for efficient Thrombin inactivation. This action modifies the blood's capacity to form a stable clot, resulting in systemic anticoagulation and the physiological halt of thrombus propagation. The drug’s action is constrained by its dependence on adequate Antithrombin levels and its reduced ability to inactivate Thrombin that is already bound to the fibrin clot.

Advertisements

Dosage and Administration Information

How to Use Heparin Sodium Injection

Heparin Sodium Injection is a parenteral medicine whose use is governed by coagulation test results. The dosage and administration are adjusted according to the patient's activated partial thromboplastin time (aPTT) to achieve a target range (e.g., 1.5 to 2.5 times the control value).

Administration Scope

Parameter Instruction Details
Route of administration The routes are Continuous Intravenous (IV) Infusion, Intermittent Intravenous (IV) Injection, and Deep Subcutaneous (SC) Injection. The medicine is not intended for intramuscular use.
Standard Adult Dosing Therapeutic IV loading doses are typically 5,000 to 10,000 units. Continuous infusion maintenance ranges from 20,000 to 40,000 units per 24 hours. For SC prophylaxis, the typical dose is 5,000 units every 8 or 12 hours.
Dosing Frequency Intermittent IV injections are given every 4 to 6 hours. Continuous infusion is administered uninterruptedly.
Preparation Requirements For continuous IV infusion, the concentrated solution must be diluted in a compatible carrier solution, such as 0.9% Sodium Chloride Injection. The solution must be clear and free of visible particles before use.
Age-Group Rules Pediatric dosing is weight-adjusted. Dosage reduction and monitoring may be advisable for older adults.
Special Conditions Coagulation status is determined at baseline and followed approximately every 4 hours in the early stages of continuous infusion for dose adjustment. High-concentration vials must not be confused with or used as “catheter lock flush” products.

The administration follows a procedure where the initial dose is followed by continuous, laboratory-guided adjustment, reflecting that the medicine's amount is defined by the patient's measured coagulation response, rather than a fixed schedule. This controlled method ensures use across administration routes.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Heparin Sodium Injection

Overview of Evidence for VTE, DVT, and Pulmonary Embolism

Unfractionated Heparin (Heparin Sodium Injection) was studied for its use in managing conditions characterized by fluctuating or episodic manifestations of blood clots, known as venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE). A vast amount of research, spanning decades of pharmacological studies, has explored its use in managing these acute, disruptive episodes.

In these studies, researchers examined outcomes monitoring physiological strain or stress, primarily focusing on measures related to clot formation and examined measures related to the progression of existing clots. These clinical trials, often conducted during periods of increased symptom activity (acute care settings), also evaluated changes in short-term functional stability and how symptoms evolved in the observed populations. Findings describe patterns observed in the studies where blood fluidity measures were monitored in high-risk, immediate scenarios.

Studies for Thromboembolic Complications

Research has also explored the use of the injection in other serious clotting conditions, such as thromboembolic complications of atrial fibrillation and peripheral arterial embolism. Research examined outcomes monitoring physiological strain or stress caused by blocked blood flow and monitored outcomes related to symptoms. This research includes evidence derived from regulatory data and general pharmacological studies.

Evidence as Supportive Therapy During Procedures

Heparin Sodium Injection was evaluated in contexts where temporary, high-level anticoagulation is required to prevent clotting outside the body. This involves its use as a supportive therapy during arterial and cardiac surgery, extracorporeal circulation (like dialysis), and blood transfusions. Research explored specific technical outcomes, such as the successful monitoring of clotting within the circuit and during the transfusion apparatus, and studies described outcomes reflecting daily functioning or activity level during the procedure. Data show patterns related to monitored coagulation measures during these controlled surgical and interventional settings.

What is Still Uncertain About Heparin Sodium Injection

While the research describes many patterns, several areas remain topics of ongoing research or uncertainty. Comparative evidence is lacking for some comparisons between Unfractionated Heparin and newer anticoagulants in specific clinical contexts. Furthermore, the available data often provide only limited insight into the long-term patient-reported experiences or subtle outcomes related to daily functioning after the acute treatment phase is completed.

Key Studies & References

  1. Heparin Sodium Injection DailyMed Label (Indications and Usage)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Heparin Sodium Injection (FAQ)

Q: What is the difference between unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH)?

A: Official documents classify Heparin Sodium Injection as Unfractionated Heparin (UFH). UFH is a large molecule with a variable structure that typically requires routine monitoring with blood tests, such as the aPTT test, for dose adjustments. Low-molecular-weight heparin (LMWH) is a modified, generally more predictable form of the drug with a shorter molecular chain.

Q: What is the difference between Heparin Sodium Injection and other 'blood thinners'?

A: Official documents indicate that Heparin Sodium (Unfractionated Heparin or UFH) is a fast-acting injectable medicine whose anticoagulant effect is easily reversible. It works by targeting specific clotting factors through the natural protein Antithrombin. Other types of 'blood thinners' often come as pills, work through different mechanisms, and have varying requirements for monitoring and reversal.

Q: Is Heparin Injection used to treat clots that have already formed?

A: Yes, official regulatory documents confirm that the drug is formally indicated for the treatment of conditions involving existing blood clots, such as deep vein thrombosis and pulmonary embolism (PE). Its primary purpose is to inhibit the further growth and propagation of these existing clots.

Q: Can Heparin Injection be used to prevent clots in healthy people?

A: Regulatory information indicates that Heparin is primarily used for prophylaxis (prevention) of blood clots in patients who are at a documented risk of developing clotting issues. This typically applies to individuals undergoing major surgery or those facing prolonged periods of reduced mobility. It is not generally indicated for use in the otherwise healthy population.

Q: How quickly does Heparin start working after it is injected?

A: According to medical guidelines, when administered by intravenous (IV) injection, the anticoagulant effect is generally considered to be immediate. If given by a deep subcutaneous (SC) injection (under the skin), the onset of action typically occurs within approximately one hour.

Q: How long does the effect of a Heparin Injection typically last in the body?

A: Pharmacological documents indicate that the effective half-life of Heparin is generally considered to be 60 to 90 minutes after IV administration. If administered by subcutaneous (SC) injection, the anticoagulant effect may persist for a longer duration, typically between 8 to 12 hours.

Q: What signs of internal bleeding should a patient look out for while on Heparin?

A: Official patient safety information advises watching for signs of bleeding such as bleeding gums, nosebleeds, unusual bruising, or the presence of blood in the urine or stools (which may appear red or black/tarry). The presence of these signs is typically a prompt for medical evaluation.

Q: What is the antidote used to reverse the effects of Heparin in an emergency?

A: Medical guidelines confirm that the substance used to rapidly reverse the anticoagulant effects of Unfractionated Heparin (UFH) in an emergency is Protamine Sulfate. This medication works by chemically binding to the Heparin molecule to form an inactive salt.

Q: Can Heparin cause long-term bone density problems (Osteoporosis) if used for a long time?

A: Regulatory product monographs advise that patients receiving long-term daily administration of Heparin Sodium Injection should be monitored. This caution is due to the potential risk for the development of osteoporosis (decreased bone density) and spontaneous fractures.

Q: Can Heparin cause skin reactions or pain at the injection site?

A: Yes, official product information confirms that reactions at the injection site are a known adverse effect. These may include common symptoms like pain, redness, and swelling. In rare, serious cases, regulatory documents have also documented skin necrosis (tissue damage).

Q: What are the signs of a severe allergic reaction to Heparin Sodium Injection?

A: Official documentation mentions that serious allergic (hypersensitivity) reactions have been reported. These severe signs can include swelling of the face or throat, shortness of breath, and hives or severe rash.

Q: Why must Heparin Sodium be given as an injection and not taken as a pill?

A: Heparin is classified as a large molecule (polysaccharide) that cannot be absorbed effectively through the digestive system. Therefore, according to pharmacological principles, it must be administered parenterally (by injection) to reach the bloodstream and become therapeutically active.

Q: Is Heparin only administered in a hospital setting?

A: Official prescribing information indicates that Heparin can be administered as a continuous intravenous (IV) infusion (usually hospital-based) or by deep subcutaneous (SC) injection. The subcutaneous route is commonly used for prevention (prophylaxis) and may be administered in an outpatient or home setting.

Q: What is the purpose of Heparin 'flushes' used for IV lines?

A: Regulatory documents describe that a special, low-concentration product called a 'heparin lock flush' is used for a specific purpose: to maintain patency (keep open and prevent blockages) in intravenous catheter devices. This ensures the catheter remains clear for intermittent injections or blood sampling.

Q: Why do different healthcare providers sometimes use different blood tests (aPTT vs. Anti-Xa) to monitor Heparin?

A: Official guidance states that regular monitoring of coagulation is required. While the aPTT test is a widely accepted measure for adjusting therapeutic dosing, the chromogenic Anti-Xa assay may also be utilized as it is often considered a more precise way to measure the actual heparin level in the blood.

Q: Is Heparin therapy always short-term?

A: Studies and medical guidelines indicate that Heparin is often used for the immediate, acute treatment phase of clotting events, which may last for a short period (e.g., several days to a week). When transitioning a patient to an oral anticoagulant, regulatory guidelines state that Heparin is given simultaneously until the oral medicine reaches its full effect.

Q: What happens if a person suddenly stops using Heparin Injection?

A: Stopping the medication can immediately lead to the loss of its therapeutic anticoagulant effect, increasing the risk of forming a blood clot. Additionally, serious adverse reactions, like Heparin-Induced Thrombocytopenia (HIT), have been documented to occur up to several weeks after the discontinuation of therapy.

Q: What happens if I miss a scheduled dose of Heparin?

A: According to patient safety guidance consistent with product labeling, if a dose is missed, it should generally be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, patients should only take the next dose, and official guidance advises against taking a double dose to make up for the missed one.

Q: What types of herbal supplements or vitamins are known to interact with Heparin?

A: While regulatory documents focus on drug-drug interactions, evidence suggests that some herbal supplements, such as garlic, ginkgo, and chondroitin, may possess their own blood-thinning properties. Official safety guidance advises that concurrent use of supplements that affect clotting should be discussed with a healthcare provider.

Q: Can Heparin be used safely before or immediately after having a spinal tap or epidural?

A: Regulatory product monographs emphasize that Heparin should be used with extreme caution during and immediately following procedures like a spinal tap or spinal/epidural anesthesia. This is because the use of Heparin significantly increases the danger of hemorrhage, including the risk of a spinal or epidural hematoma (a dangerous blood clot near the spine).

Q: If I am taking Heparin, is it okay to get a minor cut or bruise?

A: Due to Heparin's ability to reduce the blood's capacity to clot, patient safety information advises that you may experience prolonged bleeding from even minor cuts or an increase in bruising. Patients are typically advised to take measures to avoid easily sustaining cuts or injuries.

Q: Are there different brand names for Heparin Sodium Injection?

A: Yes, official product listings confirm that various pharmaceutical companies manufacture the medicine under different brand names in addition to the generic preparation of Heparin Sodium Injection.

Advertisements

How should Heparin Sodium Injection be stored and disposed of?

Storage and Disposal of Heparin Sodium Injection


Official Storage Requirements

Heparin Sodium Injection must be stored at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F). The product must not be frozen, as freezing can cause a loss of potency. Before use, the solution should be visually inspected; do not administer if the liquid is discolored or contains particulate matter.

Stability and Handling

Multi-dose vials may be used for up to 28 days after the initial puncture; the date of opening should be recorded. Any unused product remaining after 28 days must be discarded. The medication must be kept out of the sight and reach of children at all times.

Disposal Instructions

Unused medicine and waste materials, including used syringes and needles, must be disposed of in accordance with local requirements for pharmaceutical and sharps waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Heparin Sodium Injection found in:

A-Z Index: